Dentsply International Inc. (NASDAQ:XRAY)‘s stock had its “outperform” rating reiterated by equities research analysts at Robert W. Baird in a research report issued to clients and investors on Tuesday. They presently have a $67.00 price objective on the stock, down from their prior price objective of $69.00. Robert W. Baird’s target price would suggest a potential upside of 13.75% from the company’s current price.
Other equities analysts have also recently issued reports about the company. Credit Suisse Group AG restated a “buy” rating on shares of Dentsply International in a report on Sunday, June 26th. Piper Jaffray Cos. reaffirmed a “buy” rating on shares of Dentsply International in a research report on Monday, June 27th. Bank of America Corp. assumed coverage on Dentsply International in a research report on Monday, September 12th. They issued a “buy” rating and a $70.00 target price for the company. Jefferies Group reaffirmed a “buy” rating on shares of Dentsply International in a research report on Wednesday, August 17th. Finally, Zacks Investment Research cut Dentsply International from a “buy” rating to a “hold” rating in a research report on Monday, August 8th. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Dentsply International has a consensus rating of “Buy” and an average target price of $66.91.
Dentsply International (NASDAQ:XRAY) traded down 0.24% during midday trading on Tuesday, hitting $58.90. The stock had a trading volume of 1,483,791 shares. The company’s 50-day moving average price is $60.21 and its 200 day moving average price is $61.44. Dentsply International has a 12-month low of $51.62 and a 12-month high of $65.83.
Dentsply International (NASDAQ:XRAY) last issued its earnings results on Friday, August 5th. The company reported $0.76 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.70 by $0.06. The business had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Dentsply International had a return on equity of 9.18% and a net margin of 11.99%. The company’s quarterly revenue was up 46.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.73 EPS. On average, equities analysts anticipate that Dentsply International will post $2.76 earnings per share for the current fiscal year.
The business also recently announced a dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be issued a dividend of $0.0775 per share. The ex-dividend date of this dividend is Wednesday, September 28th. Dentsply International’s dividend payout ratio (DPR) is currently 14.49%.
In other Dentsply International news, SVP Maureen J. Macinnis sold 45,100 shares of the firm’s stock in a transaction dated Thursday, August 25th. The stock was sold at an average price of $60.55, for a total transaction of $2,730,805.00. Following the transaction, the senior vice president now directly owns 36,730 shares in the company, valued at $2,224,001.50. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP Rainer Berthan sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, September 6th. The shares were sold at an average price of $61.12, for a total value of $305,600.00. Following the transaction, the vice president now owns 34,370 shares in the company, valued at $2,100,694.40. The disclosure for this sale can be found here. Company insiders own 2.20% of the company’s stock.
A number of institutional investors have recently bought and sold shares of XRAY. Checchi Capital Advisers LLC raised its position in Dentsply International by 2.1% in the second quarter. Checchi Capital Advisers LLC now owns 2,007 shares of the company’s stock valued at $125,000 after buying an additional 41 shares during the period. Global X Management Co. LLC raised its position in Dentsply International by 110.1% in the second quarter. Global X Management Co. LLC now owns 3,169 shares of the company’s stock valued at $197,000 after buying an additional 1,661 shares during the period. Evercore Wealth Management LLC raised its position in Dentsply International by 12.6% in the second quarter. Evercore Wealth Management LLC now owns 3,204 shares of the company’s stock valued at $199,000 after buying an additional 358 shares during the period. Mizuho Asset Management Co. Ltd. raised its position in Dentsply International by 170.4% in the second quarter. Mizuho Asset Management Co. Ltd. now owns 3,228 shares of the company’s stock valued at $200,000 after buying an additional 2,034 shares during the period. Finally, Carnick & Kubik LLC bought a new position in Dentsply International during the first quarter valued at $201,000. Institutional investors own 94.58% of the company’s stock.
Dentsply International Company Profile
DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.
Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.